Cervical Screening: A Guideline for Clinical Practice in Ontario

Journal of Obstetrics and Gynaecology Canada

Volumn 34, Issue 5, 2012, Pages 453-458

  Murphy, Joan ^a   Kennedy, Erin B ^b   Dunn, Sheila ^c   McLachlin, C Meg ^d   Kee Fung, Michael Fung ^e   Gzik, Danusia ^f   Shier, Michael ^g   Paszat, Lawrence ^h  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f North Simcoe Muskoka Local Health Integration Network   (Canada)

^g SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^h INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

ASCUS; Cancer prevention; Cervical cancer screening; CIN; HPV testing; PEBC Program in Evidence based Care

Indexed keywords

AGE; ARTICLE; CANADA; CANCER SCREENING; CLINICAL PRACTICE; EVIDENCE BASED PRACTICE; FUNDING; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; MEDICAL DECISION MAKING; PEER REVIEW; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; VIRUS EXAMINATION; WART VIRUS; EARLY DIAGNOSIS; FEMALE; UTERINE CERVIX TUMOR;

EARLY DETECTION OF CANCER; FEMALE; HUMANS; ONTARIO; UTERINE CERVICAL NEOPLASMS;

EID: 84867593740     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)35242-2     Document Type: Article

References (28)

1. McLachlin C.M., Mai V., Murphy J., Fung-Kee-Fung M., Chambers A., Oliver T.K., et al. Ontario cervical cancer screening clinical practice guidelines. J Obstet Gynacol Can 2007, 29:344-353.
2. Miller A.B., Anderson G., Brisson J., Laidlaw J., Le Pitre N., Malcolmson P., et al. Report of a National Workshop on Screening for Cancer of the Cervix 1991, 145:1301-1325.
3. Moscicki A.B. Cervical cytology testing in teens. Curr Opin Obstet Gynecol 2005, 17:471-475.
4. Browman G.P., Levine M.N., Mohide E.A., Hayward R.S.A., Pritchard K.I., Gafni A. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995, 13:502-512.
5. cancerviewcanada.ca [website] 2011, Canadian Partnership Against Cancer, Toronto, ON, updated, Available at, Accessed March 13, 2012. http://www.cancerview.ca.
6. Brouwers M.C., Kho M.E., Browman G.P., Burgers J.S., Cluzeau F., Feder G., et al. AGREE II: Advancing guideline development, reporting, and evaluation in health care. Prev Med 2010, 51:421-424.
7. Naucler P., Ryd W., Tornberg S., Strand A., Wadell G., Elfgren K., et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007, 357:1589-1597.
8. Bulkmans N.W., Berkhof J., Rozendaal L., van Kemenade F.J., Boeke A.J., Bulk S., et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007, 370:1764-1772.
9. Anttila A., Kotaniemi-Talonen L., Leinonen M., Hakama M., Laurila P., Tarkkanen J., et al. Rate of cervical cancer, severe intraepithelial neoplasia,and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. BMJ 2010, 340:1804. c.
10. Ronco G., Giorgi-Rossi P., Carozzi F., Confortini M., Dalla Palma P., Del Mistro A., et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia:a randomised controlled trial. Lancet Oncol 2010, 11:249-257.
11. Kitchener H.C., Almonte M., Thomson C., Wheeler P., Sargent A., Stoykova B., et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 2009, 10:672-682.
12. Mayrand M., Duarte-Franco E., Rodrigues I., Walter S.D., Hanley J., Ferenczy A., et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007, 357:1579-1588.
13. Sankaranarayanan R., Nene B.M., Shastri S.S., Jayant K., Muwonge R., Budukh A.M., et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009, 360:1385-1394.
14. Andrae B., Kemetli L., Sparen P., Silfverdal L., Strander B., Ryd W., et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008, 100:622-629.
15. Crocetti E., Battisti L., Betta A., Palma P.D., Paci E., Piffer S., et al. The cytological screening turned out effective also for adenocarcinoma:a population-based case-control study in Trento, Italy. Eur J Cancer Prev 2007, 16:564-567.
16. Sasieni P., Castanon A., Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ 2009, 339:2968. b.
17. Castle P.E., Rodriguez A.C., Burk R.D., Herrero R., Wacholder S., Alfaro M., et al. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ 2009, 339:2569. b.
18. Kjaer S.K., Frederiksen K., Munk C., Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst 2010, 102:1478-1488.
19. Dillner J., Rebolj M., Birembaut P., Petry K.U., Szarewski A., Munk C., et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 2008, 337:1754. a.
20. Cuzick J., Arbyn M., Sankaranarayanan R., Tsu V., Ronco G., Mayrand M.H., et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008, 26(10):29-41. Suppl.
21. Murphy J., Kennedy E.B., Dunn S., McLachlin M., Fung Kee Fung M., Gzik D., et al. HPV testing in primary cervical screening: a systematic review and meta-analysis. J Obstet Gynaecol Can 2012, 34(5):443-452.
22. Leinonen M., Nieminen P., Kotaniemi-Talonen L., Malila N., Tarkkanen J., Laurila P., et al. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 2009, 101:1612-1623.
23. Bartholomew D.A. Human papillomavirus infection in adolescents: a rational approach. Adolesc Med Clin 2004, 15:569-595.
24. Roland K.B., Soman A., Benard V.B., Saraiya M. Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States. Am J Obstet Gynecol 2011, 205-447. e1-e8.
25. Sirovich B.E., Woloshin S., Schwartz L.M. Screening for cervical cancer: will women accept less?. Am J Med 2005, 118:151-158.
26. Zhang Y., Borders T.F., Rohrer J.E. Correlates of intent to seek unnecessary pap tests among elderly women. Womens Health Issues 2007, 17:351-359.
27. Kyrgiou M., Koliopoulos G., Martin-Hirsch P., Arbyn M., Prendiville W., Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006, 367:489-498.
28. Schiffman M., Wentzensen N., Wacholder S., Kinney W., Gage J.C., Castle P.E. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011, 103:1-16.